| Record ID | ia:antiviralchemoth0000unse_u6s4 |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/antiviralchemoth0000unse_u6s4/antiviralchemoth0000unse_u6s4_marc.xml |
| Download MARC binary | https://www.archive.org/download/antiviralchemoth0000unse_u6s4/antiviralchemoth0000unse_u6s4_meta.mrc |
LEADER: 01243cam 2200301 a 4500
001 93019985 //r94
003 DLC
005 19940617101352.0
008 930105s1993 njua b 101 0 eng c
010 $a 93019985 //r94
020 $a0130507172 (alk. paper)
040 $aDNLM/DLC$cDLC$dDLC
050 00 $aRC114.5$b.A555 1993
060 $aWC 500 A6335 1993
082 00 $a616.9/25061$220
245 00 $aAntiviral chemotherapy :$bnew directions for clinical applications and research /$ceditors, John Mills, Lawrence Corey.
260 $aEnglewood Cliffs, N.J. :$bPTR Prentice Hall,$cc1993.
300 $axiii, 450 p. :$bill. ;$c24 cm.
500 $a"Proceedings of the third Triennial Conference on Antiviral Chemotherapy, held in San Francisco in November, 1991"--Pref.
500 $a"Volume 3."
504 $aIncludes bibliographical references and index.
650 0 $aVirus diseases$xChemotherapy$xCongresses.
650 0 $aAntiviral agents$xCongresses.
650 2 $aAntiviral Agents$xtherapeutic use$xcongresses.
650 2 $aVirus Diseases$xdrug therapy$xcongresses.
700 10 $aMills, John,$d1940-
700 10 $aCorey, Lawrence.
711 20 $aTriennial Conference on Antiviral Chemotherapy$n(3rd :$d1991 :$cSan Francisco, Calif.)